Top Markets
#1 Nesa Nesa +719.77%
#2 EXOD EXOD +22.78%
#3 Pons Pons +11.59%
#4 MetaDAO MetaDAO +11.24%
#5 Venom Venom +10.59%
#6 Ontology Gas Ontology Gas +9.15%
#7 Status Status +9.08%
#8 PondCoin PondCoin +8.69%
#9 Prom Prom +7.99%
#10 Wrapped NXM Wrapped NXM +7.71%
Coin of the day
Nesa Nesa
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Connect Biopharma Holdings Limited Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

CNTB
Rang în acțiuni #19727
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical... Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
Preț acțiune
$2.42
Ultima sincronizare: 2026-08-25
Capitalizare de piață
$152.37M
Schimbare (1 zi)
5.22%
Schimbare (1 an)
39.88%
Țară
US
Tranzacționează Connect Biopharma Holdings Limited (CNTB)

Categorie

Healthcare
Istoric al prețului acțiunii pentru Connect Biopharma Holdings Limited (CNTB)
Cel mai mare preț de închidere: $2.35 pe 2026-08-01

Cel mai mic preț de închidere: $17.02 pe 2021-03-01
Istoric al prețului acțiunii pentru Connect Biopharma Holdings Limited din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -8.60%
2025 129.78%
2024 18.63%
2023 21.12%
2022 -83.36%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.02 -11.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH